Neurologist Dr. Richard Reimer will discuss who is at risk for ALS, Alzheimer's and Parkinson's and the development of new treatments enabled by technological advances, at 7:30 p.m. April 8. The event, being presented by the Rae Dorough Speaker Series in conjunction with the Livermore Lab Foundation, will be held online.

Reimer will provide an overview of common neurodegenerative diseases including Alzheimer's, Parkinson's and amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease. Using ALS as an example, he will present the evidence for the role that aging, genetics and the environment play in disease onset and progression.

He will conclude with a discussion of efforts to develop treatments for ALS, notably the targeting of established risk factors and the use of unanticipated factors discovered through machine learning -- an area of focus for Lawrence Livermore National Laboratory.

Reimer is an associate professor in the department of neurology and neurological sciences at Stanford University School of Medicine and a staff neurologist for the Palo Alto Veterans Affairs Health Care System.

Tickets for the livestream presentation are $10 each, with proceeds benefiting ALS Research through the Livermore Lab Foundation and the ALS CURE Project. To attend, call the Bankhead Theater at 373-600, email [email protected], or go to livermorearts.org.